James E. Flynn is Director & 10% at Talon Therapeutics, Inc. (TLON.OB). They have made 83 open-market trades across 47 companies since 2006, most recently 2026-06-16.
39 open-market purchases totalling $221.8M since 2006, against 44 sales. Across 32 scored buys the stock is down 3.9% at ninety days, and 6.7 points behind the S&P over the same stretch.
32 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 25% | 34% | 31% |
| Avg Move | -9.8% | -4.6% | -3.9% |
| Alpha | -7.6% | -5.7% | -6.7% |
| Scored | 32 | 32 | 32 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 53% | 62% | 74% |
| Avg Move | -4.2% | +3.6% | -7.0% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LRMR | BUY | 2026-02-27 | 2026-03-02 | $5.00 | $25.0M | -14.5% | -16.3% | -36.9% |
| NUVL | SELL | 2025-11-24 | 2025-11-24 | $95.45 | $70.9M | +0.5% | -3.0% | -5.5% |
| SPRY | SELL | 2025-06-27 | 2025-07-01 | $18.46 | $27.3M | +12.9% | +11.5% | -38.7% |
| ONCR | SELL | 2022-12-28 | 2022-12-30 | $0.26 | $65K | +15.0% | +54.1% | +20.8% |
| ONCR | SELL | 2022-12-19 | 2022-12-21 | $0.29 | $23K | +8.3% | +42.7% | +30.5% |
| AFIB | BUY | 2021-07-19 | 2021-07-21 | $14.00 | $15.0M | +2.5% | -12.6% | -44.6% |
| OMIC | BUY | 2021-06-01 | 2021-06-03 | $22.00 | $33.0M | -12.1% | -2.6% | -35.6% |
| HOWL | BUY | 2021-05-04 | 2021-05-04 | $16.00 | $12.8M | -29.5% | -21.6% | +0.4% |
| ONCR | BUY | 2021-02-17 | 2021-02-18 | $19.00 | $3.2M | -12.0% | -14.2% | -15.0% |
| TERN | BUY | 2021-02-09 | 2021-02-09 | $17.00 | $11.3M | -8.5% | +5.5% | -32.5% |
| FIXX | SELL | 2019-12-19 | 2019-12-23 | $21.78 | $3.6M | -16.4% | -26.5% | -31.0% |
| FREQ | BUY | 2019-10-07 | 2019-10-07 | $14.00 | $4.0M | -7.1% | +12.6% | +23.0% |
| MIRM | BUY | 2019-07-22 | 2019-07-24 | $15.00 | $2.5M | -5.9% | +0.4% | -47.4% |
| ACRS | SELL | 2019-06-27 | 2019-07-01 | $2.69 | $1.9M | -9.5% | -46.9% | -55.2% |
| ACRS | SELL | 2019-06-21 | 2019-06-25 | $4.59 | $2.1M | -51.7% | -60.7% | -71.1% |
| ACRS | SELL | 2019-05-10 | 2019-05-13 | $6.05 | $1.1M | -11.8% | -18.4% | -85.1% |
| ACRS | SELL | 2019-05-09 | 2019-05-13 | $6.12 | $6.5M | -11.8% | -18.4% | -85.1% |
| ACRS | SELL | 2019-05-09 | 2019-05-13 | $6.16 | $2.7M | -11.8% | -18.4% | -85.1% |
| SWAV | BUY | 2019-03-11 | 2019-03-11 | $17.00 | $170K | +15.8% | +1.5% | +125.4% |
| XERS | SELL | 2019-01-28 | 2019-01-30 | $15.13 | $200K | -0.7% | -31.2% | -31.1% |
| XERS | SELL | 2019-01-23 | 2019-01-25 | $15.43 | $3.5M | -1.1% | -31.8% | -35.8% |
| ARVN | BUY | 2018-10-01 | 2018-10-01 | $16.00 | $3.3M | -14.4% | +1.6% | -19.7% |
| CNST | BUY | 2018-07-23 | 2018-07-23 | $15.00 | $3.0M | -9.4% | -11.6% | -40.7% |
| RYTM | BUY | 2017-10-10 | 2017-10-10 | $17.00 | $3.0M | -12.2% | -16.3% | +5.8% |
| REPH | SELL | 2017-06-12 | 2017-06-14 | $6.44 | $920K | +17.7% | +18.6% | +25.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ATRS | 6,807,533 | $38.1M |
| DRNA | 848,785 | $32.4M |
| FIXX | 1,917,339 | $32.2M |
| ALIM | 4,624,284 | $25.6M |
| NXTM | 777,102 | $23.3M |
| CNST | 635,843 | $21.6M |
| SPRY | 4,887,254 | $19.6M |
| XNPT | 2,148,856 | $15.2M |
| LRMR | 6,207,982 | $12.4M |
| XERS | 884,728 | $9.1M |
| LIFE | 230,764 | $8.6M |
| DVAX | 537,363 | $8.3M |
| CASM | 2,876,086 | $7.0M |
| FREQ | 285,714 | $4.3M |
| NURO | 920,455 | $4.2M |
| ZFGN | 314,889 | $3.7M |
| ACRS | 964,101 | $3.2M |
| VNDA | 693,171 | $2.8M |
| REPH | 1,244,685 | $2.6M |
| ARVN | 307,078 | $2.1M |
| BOLD | 889,230 | $2.1M |
| FCSC | 637,200 | $1.9M |
| HOWL | 1,752,787 | $1.7M |
| CTMX | 275,000 | $627K |
| NEOS | 429,166 | $494K |
| NUVL | 3,444 | $427K |
| DFBH | 26,087 | $253K |
| EHTH | 244,562 | $142K |
| SYRS | 628,566 | $75K |
| ONCR | 284,697 | $34K |
| AFIB | 20,822 | $2K |
| SLXP | 2,223,766 | — |
| ISPH | 752,186 | — |
| NGSX | 987,880 | — |
| NTMD | 1,940,849 | — |
| EMAGEON | 1,173,658 | — |
| ISTA | 342,061 | — |
| CMAX | 12,123 | — |
| TLON.OB | 6,936,567 | — |
| TRIV | 324,524 | — |
| TWTI | 734,795 | — |
| VIAP | 748,049 | — |
| Total | $1.3B |
Shares reported on the most recent Form 4, priced at the 2026-06-18 close. 11 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 34 | 34 | 34 |